During the corresponding time, Hologic Inc recorded a revenue increase by 44.84 % year on year, sequentially revenue fell by -46.45 %. While revenue at the Hologic Inc's corporate clients
Hologic Inc's Comment on Sales, Marketing and Customers
Hologic provides automated systems for consolidating lab developed tests (LDTs) and in vitro diagnostic (IVD) assays. Its Breast Health segment serves the breast imaging, biopsy, breast surgery, and pathology markets with products including 3D digital mammography systems, AI-based image analysis software, biopsy guidance systems, and specimen radiology systems. Key breast imaging platforms include Selenia Dimensions and 3Dimensions. The GYN Surgical segment offers products for hysteroscopic tissue removal, endometrial ablation, fluid management, transcervical and laparoscopic radiofrequency ablation, vessel sealing, and surgical stapling. Devices in this segment include MyoSure, NovaSure, Fluent, Sonata, Acessa ProVu, CoolSeal, and the JustRight stapler. The Skeletal Health segment provides bone density and body composition assessment systems, such as Horizon DXA, and orthopedic surgical imaging with the Fluoroscan Insight FD mini C-arm. Sales of the Fluoroscan Insight FD are scheduled to discontinue in fiscal 2026.
Hologic Inc’s Comment on Sales, Marketing and Customers
Hologic provides automated systems for consolidating lab developed tests (LDTs) and in vitro diagnostic (IVD) assays. Its Breast Health segment serves the breast imaging, biopsy, breast surgery, and pathology markets with products including 3D digital mammography systems, AI-based image analysis software, biopsy guidance systems, and specimen radiology systems. Key breast imaging platforms include Selenia Dimensions and 3Dimensions. The GYN Surgical segment offers products for hysteroscopic tissue removal, endometrial ablation, fluid management, transcervical and laparoscopic radiofrequency ablation, vessel sealing, and surgical stapling. Devices in this segment include MyoSure, NovaSure, Fluent, Sonata, Acessa ProVu, CoolSeal, and the JustRight stapler. The Skeletal Health segment provides bone density and body composition assessment systems, such as Horizon DXA, and orthopedic surgical imaging with the Fluoroscan Insight FD mini C-arm. Sales of the Fluoroscan Insight FD are scheduled to discontinue in fiscal 2026.
Sources:
Hologic Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Hologic Inc’s corporate clients.
For your research, we’ve provided 9 tables on Hologic Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
0 %